Artra Group Corporation (6029) AI Stock Analysis

• Market Cap: ¥1.41B
• Dividend Yield: N/A
• Average Volume (3M): 89.29K
• Price to Earnings (P/E): 6.8
• Beta (1Y): 0.81
• Revenue Growth: -10.34%
• EPS Growth: 259.78%
• Country: JP
• Employees: 142
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 7.73
• Shares Outstanding: 10,287,000
• 10 Day Avg. Volume: 88,380
• 30 Day Avg. Volume: 89,290
• PEG Ratio: >-0.01
• Price to Book (P/B): 1.03
• Price to Sales (P/S): 0.44
• P/FCF Ratio: 7.08
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 57 Neutral
• Price Target: ¥146.00 ▼(-14.12% Downside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is primarily supported by improving financial health (profitability recovery and deleveraging) and a low P/E valuation, but is held back by weak technicals (below major moving averages with negative momentum) and the fundamental risk of multi-year revenue contraction and earnings/cash-flow volatility.

Positive Factors

Margin recovery & gross margin

Sustained improvement in gross and net margins indicates better pricing power or cost control in core printing operations. Higher margins increase resilience to revenue swings, improve cash conversion and provide room to invest in efficiency or product quality over the next several quarters.

Negative Factors

Multi-year revenue contraction

A persistent top-line decline erodes scale benefits in a manufacturing/printing business, reducing capacity utilization and squeezing long-run unit economics. Continued revenue shrinkage limits margin expansion potential and constrains reinvestment or diversification options.

Artra Group Corporation Business Overview & Revenue Model

Company Description

Artra Group Corporation provides support services for acupuncture and osteopathic hospitals in Japan. The company offers billing services; and HONEY-STYLE, a system, which specializes in word-of-mouth/reservation system for acupuncture and moxibus...

Read more

Artra Group Corporation provides support services for acupuncture and osteopathic hospitals in Japan. The company offers billing services; and HONEY-STYLE, a system, which specializes in word-of-mouth/reservation system for acupuncture and moxibus...

How the Company Makes Money

Artra Group Corporation generates revenue mainly by selling printing and printing-related products and services to business customers. Key revenue streams typically include (1) fees from providing printing services (e.g., production/processing wor...

Read more

Artra Group Corporation generates revenue mainly by selling printing and printing-related products and services to business customers. Key revenue streams typically include (1) fees from providing printing services (e.g., production/processing wor...

Artra Group Corporation Financial Statement Overview

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	4.07B	3.93B	4.23B	4.50B	4.67B	3.16B
Gross Profit	1.35B	1.35B	1.33B	1.46B	1.57B	876.25M
EBITDA	318.30M	246.22M	146.84M	228.12M	190.55M	-163.55M
Net Income	142.57M	258.29M	-36.74M	53.00M	2.10M	-351.12M
Balance Sheet
Total Assets	3.81B	4.13B	4.11B	4.57B	4.65B	5.60B
Cash, Cash Equivalents and Short-Term Investments	1.02B	1.13B	1.05B	1.14B	1.23B	1.84B
Total Debt	1.18B	1.05B	1.29B	1.54B	1.91B	2.44B
Total Liabilities	2.26B	2.43B	2.68B	3.13B	3.35B	4.16B
Stockholders Equity	1.55B	1.70B	1.44B	1.45B	1.31B	1.44B
Cash Flow
Free Cash Flow	0.00	246.64M	122.36M	142.00M	-288.93M	-264.76M
Operating Cash Flow	0.00	287.21M	200.85M	217.00M	-132.55M	-208.56M
Investing Cash Flow	0.00	24.68M	-31.16M	-11.00M	-154.17M	-563.84M
Financing Cash Flow	0.00	-233.24M	-259.74M	-300.00M	-314.62M	895.50M

Artra Group Corporation Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 170.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6029, the sentiment is Negative. The current price of 170 is above the 20-day moving average (MA) of 145.00, above the 50-day MA of 159.16, and below the 200-day MA of 177.89, indicating a bearish trend. The MACD of -5.27 indicates Negative momentum. The RSI at 31.34 is Neutral, neither overbought nor oversold. The STOCH value of 30.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6029.

Artra Group Corporation Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9220	81 Outperform	¥2.88B	4.69	―	2.82%	4.82%	9.78%
2425	74 Outperform	¥2.98B	27.02	―	2.56%	-3.06%	-38.56%
9214	69 Neutral	¥2.01B	15.41	―	―	32.45%	58.25%
6029	57 Neutral	¥1.41B	6.76	―	―	-10.34%	259.78%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
2373	51 Neutral	¥5.72B	23.20	―	4.07%	6.08%	38.00%
7362	49 Neutral	¥1.24B	14.80	―	―	2.81%	-42.50%